Last year marked the eleventh anniversary of China’s Anti-Monopoly Law (the “AML”). In 2019, China announced the first-ever set of proposed amendments to the AML as well as the introduction of several new regulations aimed at more transparency and efficiency in antitrust enforcement and codifying noteworthy deviations between Chinese and United States and European Union antitrust laws.
In the past year, the State Administration for Market Regulation (“SAMR”) approved five transactions with conditions (i.e., remedies), a slight uptick from four in 2018. The average review time for these five transactions was approximately one year. SAMR did … Read more